The groundbreaking approach of the medication represents a significant development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – https://tirzepatidepeptide825034.blogitright.com/42355652/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment